Literature DB >> 10592228

The prostate expression database (PEDB): status and enhancements in 2000.

P S Nelson1, N Clegg, B Eroglu, V Hawkins, R Bumgarner, T Smith, L Hood.   

Abstract

The Prostate Expression Database (PEDB) is an online resource designed to access and analyze gene expression information derived from the human prostate. PEDB archives >55 000 expressed sequence tags (ESTs) from 43 cDNA libraries in a curated relational database that provides detailed library information including tissue source, library construction methods, sequence diversity and sequence abundance. The differential expression of each EST species can be viewed across all libraries using a Virtual Expression Analysis Tool (VEAT), a graphical user interface written in Java for intra- and inter-library species comparisons. Recent enhancements to PEDB include: (i) the functional categorization of annotated EST assemblies using a classification scheme developed at The Institute for Genome Research; (ii) catalogs of expressed genes in specific prostate tissue sources designated as transcriptomes; and (iii) the addition of prostate proteome information derived from two-dimensional electrophoreses and mass spectrometry of prostate cancer cell lines. PEDB may be accessed via the WWW at http://www.mbt.washington.edu/PEDB/

Entities:  

Mesh:

Year:  2000        PMID: 10592228      PMCID: PMC102457          DOI: 10.1093/nar/28.1.212

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  6 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  PEDB: the Prostate Expression Database.

Authors:  V Hawkins; D Doll; R Bumgarner; T Smith; C Abajian; L Hood; P S Nelson
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

Review 3.  Pieces of the puzzle: expressed sequence tags and the catalog of human genes.

Authors:  G D Schuler
Journal:  J Mol Med (Berl)       Date:  1997-10       Impact factor: 4.599

4.  Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.

Authors:  M D Adams; A R Kerlavage; R D Fleischmann; R A Fuldner; C J Bult; N H Lee; E F Kirkness; K G Weinstock; J D Gocayne; O White
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

5.  dbEST--database for "expressed sequence tags".

Authors:  M S Boguski; T M Lowe; C M Tolstoshev
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

6.  An improved sequence assembly program.

Authors:  X Huang
Journal:  Genomics       Date:  1996-04-01       Impact factor: 5.736

  6 in total
  6 in total

Review 1.  Molecular biologist's guide to proteomics.

Authors:  Paul R Graves; Timothy A J Haystead
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

2.  Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Authors:  Ilsa M Coleman; Jeffrey A Kiefer; Lisha G Brown; Tiffany E Pitts; Peter S Nelson; Kristen D Brubaker; Robert L Vessella; Eva Corey
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

3.  Adenoviral gene therapy, radiation, and prostate cancer.

Authors:  Shawn E Lupold; Ronald Rodriguez
Journal:  Rev Urol       Date:  2005

4.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  British Cancer Research Meeting 2001. Leeds, United Kingdom, 1-4 July 2001. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  2001-07       Impact factor: 7.640

Review 6.  Prostate cancer genomics.

Authors:  P E Li; P S Nelson
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.